In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

Shares of Novavax Inc. NVAX shed 5.04% to $12.63 Monday, on what proved to be an all-around great trading session for the ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...

Last year only 23% of Americans got an updated COVID-19 vaccine, according to the CDC. They recommend those six months and ...

On Friday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $13.3 which represents a slight increase of $1.15 or 9.47% from the prior close of $12.15. The stock opened at $12.32 and ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

The Ministry of Food and Drug Safety approved Novavax's vaccine for emergency use today (30th) in response to the "COVID-19 ...

The new XEC variant A new hybrid Covid variant, XEC, has emerged in 25 states across the US, and experts predict it will ...